A fight over who sets the price
On the surface, this is a dispute about women’s healthcare. Underneath, it is a fight over who gets to set the price of private medicine in New Zealand, and the outcome lands squarely on employers who fund staff health cover.
Southern Cross Health Insurance has told the Commerce Commission that the New Zealand Gynaecology Association’s bid to collectively negotiate contracts is about preserving prices “significantly above competitive levels”, not protecting patients. It is a sharp reframing. The gynaecologists have cast the insurer’s proposal as a clinical safety issue. Southern Cross is calling it what it says it really is, a competition and affordability problem.
What Southern Cross actually wants
The insurer wants to restructure how gynaecologists are paid. Rather than contracting directly with each specialist, it proposes back-to-back contracts where hospitals become head contractors and gynaecologists become subcontractors, with each procedure assigned a code and a fixed fee set under Southern Cross’s affiliated provider system.
The specialists say the numbers are brutal. Under the model, the NZGA’s Commerce Commission application warns compensation could fall 30 to 50% against current levels. They argue fixed pricing ignores procedure and patient complexity and that the coding system is deficient in urogynaecology and gynaecology oncology.
The association is seeking authorisation to bargain collectively for up to ten years plus a standstill of up to six months. Collective action by competing businesses is normally illegal, which is why they need the Commission’s sign-off. The Commission has until 22 October 2026 to decide. And this is not just a gynaecology matter. The New Zealand Society of Anaesthetists has flagged the case to its members, a sign it is a test case for specialist costs across the board.
The deficits are not an abstraction
Southern Cross is a mutual society with no shareholders. When it loses money, members pay, and members include the employers who buy group cover.
The FY2025 annual report records a $56.9 million deficit, an improvement on the $99.1 million loss the year before but still a serious hole. Premium income rose 13% to $1.966 billion, yet incurred claims rose faster at 14% to $1.783 billion. That gap is the whole problem in one line.
The insurer says medical inflation is running at roughly 15% per annum, with member adjusted claims costs up 12.2% against a pre-pandemic long-run average near 6.5%. Compare that to general CPI inflation of 3.1% in the year to March 2026. Health costs are climbing at multiples of the wider economy. Southern Cross paid a record 3.8 million claim lines, up 16%, and returned 94 cents of every premium dollar to members.
The warning nobody listened to
This is not the first time Southern Cross has raised the alarm. Back in 2021, its then-chief medical officer Stephen Child used the insurer’s own claims data to expose staggering fee variation. Gynaecologists billed between $49 and $122 per minute for a hysterectomy, a six-fold spread for the same procedure. One surgeon charged $12,000 for 34 minutes in theatre. At the time Child warned, “we’re killing the golden goose here.”
That warning was ignored. Five years on, Southern Cross has stopped appealing to voluntary restraint and is trying to impose structural pricing discipline instead. The question is whether the Commerce Commission will let it.
Why employers should care
Southern Cross controls 60% of the health insurance market by customer numbers and pays 68% of all health insurance claims. Its cost trajectory is your cost trajectory.
Premium rises of 13% compound fast. A firm paying $500,000 a year in group premiums faces an extra $65,000 at that rate, before the next increase. If the insurer cannot rein in specialist inflation, those rises keep coming. If it succeeds but drives specialists out of the network, staff hit gap fees and reduced access, which hollows out the very benefit employers are paying to provide. Neither outcome is comfortable.
The October determination is the bellwether. It will signal whether insurers or specialists set the price of private medicine, and by extension whether employer health cover stays a manageable retention tool or turns into an open-ended liability. Either way, the people writing the cheques should be watching this Commerce Commission file closely.
Sources
- Insurer says gynaecologists’ bid is about protecting margins, not patients (2026-07-07)
- Warning over what major insurer’s proposal means for women’s healthcare (2026-06-30)
- NZ Gynaecology Assoc seeks authorisation to engage in collective bargaining with Southern Cross (2026-05-29)
- NZGA Authorisation Application (2026-05-19)
- Commerce Commission Application from NZGA – Consultation (2026-05-29)
- Huge variation in surgeons’ fees questioned (2021-08-13)
- Southern Cross Medical Care Society Group 2025 Annual Report (2025-09-30)
- Consumers price index: March 2026 quarter (2026-03-31)
- Delivering for members more than ever (2025-09-30)